Statins

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
17:04

Cardiometabolic Health Congress (CMHC)

Part 2 - What Have We Learned from the CANTOS Trial and Looking Forward?

  • 97 views
  • October 22, 2019
  • 1
16:23

Cardiometabolic Health Congress (CMHC)

Part 1 - Targeting Inflammation- Updates on Pathophysiology and Clinical Outcomes

FEATURING Peter Libby
  • 97 views
  • October 22, 2019
  • 1
17:42

Cardiometabolic Health Congress (CMHC)

Infographic Primer Review and Interactive Patient Case Consults: Tips and Strategies to Obtain PA

FEATURING Pamela B. Morris
  • 59 views
  • October 22, 2019
06:41

Cardiometabolic Health Congress (CMHC)

Interactive Patient Case Consults: Tips and Strategies to Obtain PA (Case 2)

FEATURING Kim Birtcher
  • 15 views
  • October 22, 2019
08:11

Cardiometabolic Health Congress (CMHC)

Interactive Patient Case Consults: Tips and Strategies to Obtain PA

FEATURING Christie Ballantyne
  • 17 views
  • October 22, 2019
14:11

Cardiometabolic Health Congress (CMHC)

Mastering the Prior Authorization Process to Meet Patient Needs, Audience Q&A

FEATURING Pamela B. Morris, Christie Ballantyne, Kim Birtcher
  • 43 views
  • October 22, 2019
15:08

Cardiology Pulse 2019

Top 5 Cardiovascular Prevention Trials

FEATURING Robert Chilton
  • 267 views
  • October 30, 2019
  • 3
14:44

National Lipid Association

Bempedoic Acid: Mechanism of Action, Effects and Potential Uses

FEATURING Anne Goldberg
  • 842 views
  • March 19, 2020
  • 3
20:22

National Lipid Association

Update on Pharmacotherapy for Obesity

FEATURING Harold Bays
  • 789 views
  • March 23, 2020
  • 2
16:40

Houston Methodist DeBakey Heart and Vascular Center

Update on Inflammation & Atherosclerosis Treatment: Should All Atherosclerosis Patients Receive Aggressive Lipid-Lowering and Inflammation Inhibiting Therapy? Why Not Combine Anti-Inflammatory Therapy with PCSK9 Inhibition?

FEATURING Paul Ridker
  • 1,523 views
  • July 14, 2020
  • 9
08:41

Cardiometabolic Health Congress (CMHC)

2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

FEATURING Salim Virani
  • 896 views
  • September 22, 2020
  • 3
09:03

Cardiometabolic Health Congress (CMHC)

2020 Update on Statin Therapy in ASCVD: Why Does Residual Risk Occur in Clinical Practice? Can the Big Data Asist in Identifying Patients With SASEs? Why Are System-Level Interventions Needed?

FEATURING Salim Virani
  • 121 views
  • September 22, 2020
19:24

Cardiometabolic Health Congress (CMHC)

2020 Update on LDL-C Reduction: Does Aggressive LDL-C Lowering Therapy Eliminates CVD Risk? What Are the Benefits of LDL Lowering on Plaque Regression?

FEATURING Pam Taub
  • 903 views
  • September 22, 2020
  • 9
15:14

Cardiometabolic Health Congress (CMHC)

55 y/o Female With Hypertension, Hypothyroidism, and Metabolic Syndrome: How to Optimize LDL-C Reduction Therapy?

FEATURING Salim Virani, Christie Ballantyne, Pam Taub
  • 441 views
  • September 22, 2020
  • 2
19:34

Cardiometabolic Health Congress (CMHC)

Q&A on Novel Therapies and Approaches in LDL-C Reduction

FEATURING Salim Virani, Christie Ballantyne, Pam Taub
  • 605 views
  • September 22, 2020
24:35

Keck School of Medicine of USC

Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?

FEATURING Steven Nissen
  • 947 views
  • January 5, 2021
  • 13
17:57

Cardiometabolic Health Congress (CMHC)

CMHC Tsunami Expert Discussion on Nutrition, Insulin Therapy, Practical Tips for Telemedicine, and the Link Between Hyperinsulinemia & Atherosclerosis

FEATURING Margo Minissian, Robert Eckel, Keith Ferdinand
  • 60 views
  • January 15, 2021
19:46

Cardiometabolic Health Congress (CMHC)

ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol?

FEATURING Margo Minissian
  • 165 views
  • January 18, 2021
  • 1
08:30

University of Colorado Department of Medicine

NAFLD Pharmacologic Management: What Are the Benefits & Safety Concerns of Vitamin E and Pioglitazone? What Is the Efficacy of OCA?

FEATURING Amanda Wieland
  • 126 views
  • February 2, 2021
22:01

University of Colorado Department of Medicine

NAFLD Epidemiology & Diagnosis: When to Screen? What Are the Indications for Transplantation? Is Statin Therapy Safe for NAFLD/NASH?

FEATURING Amanda Wieland
  • 80 views
  • February 2, 2021

Statins

Recommended Topics:

PCSK9

All Topics: